Prophylactic Effects of Agomelatine for Poststroke Depression
Condition(s):Depression; Acute Ischemic StrokeLast Updated:July 27, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Depression; Acute Ischemic StrokeLast Updated:July 27, 2022Not yet recruiting
Condition(s):Major Depression; FibromyalgiaLast Updated:May 7, 2014Completed
Condition(s):Hepatic ImpairmentLast Updated:May 11, 2021Completed
Condition(s):Schizophrenia; Schizoaffective Disorder; Delusional DisorderLast Updated:March 8, 2018Completed
Condition(s):Renal ImpairmentLast Updated:December 8, 2020Completed
Condition(s):Major Depressive Disorder (MDD)Last Updated:December 18, 2013Unknown status
Condition(s):Major Depressive DisorderLast Updated:December 23, 2020Completed
Condition(s):Major Depressive DisorderLast Updated:November 29, 2019Completed
Condition(s):Obsessive Compulsive DisorderLast Updated:January 3, 2020Completed
Condition(s):Parkinson Disease; Depression; Sleep Disorders; Circadian Rhythm DisordersLast Updated:June 6, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.